Search research articles
Contact Us
Filters
Showing results (291-300 of 458) with videos related to
Page
of 46
Sort By:
British Journal of Clinical Pharmacology
|
October 1, 1989
Atrial natriuretic peptide and urinary prostaglandins in man
D Benzoni, J Geoffroy, B Waeber, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1987
Acute antihypertensive effect of angiotensin converting enzyme inhibition and calcium entry blockade
H R Brunner, J Nussberger, J Bidiville, et al.
Life Sciences
|
December 7, 1987
Markedly reduced blood pressure responsiveness in endotoxemic rats; reversal by neuropeptide Y
D Evéquoz, B Waeber, R Corder, et al.
Clinical and Experimental Pharmacology & Physiology
|
February 1, 1994
Mechanisms of the pressor response to intravenous thyrotropin-releasing hormone in the rat
D Evequoz, M Burnier, M Niederberger, et al.
Kidney International. Supplement
|
June 1, 1996
Pharmacokinetic-pharmacodynamic relationships of three angiotensin II receptor antagonists in normal volunteers
M Burnier, T Buclin, J Biollaz, et al.
Journal of Cardiovascular Pharmacology
|
December 1, 1994
Neuropeptide Y infusion decreases plasma renin activity in postmyocardial infarction rats
R Zelis, J Nussberger, B Clemson, et al.
Experientia
|
October 15, 1994
Differential vascular effects of neuropeptide Y(NPY) selective receptor agonists
D Evéquoz, E Grouzmann, A G Beck-Sickinger, et al.
Schweizerische Medizinische Wochenschrift
|
December 31, 1983
[Treatment of hypertensive crisis with captopril]
J Biollaz, B Waeber, G A Turini, et al.
European Journal of Pharmacology
|
June 17, 1986
The hemodynamic response of conscious normotensive rats to atriopeptin III: Lack of a role of the parasympathetic nervous system
B Waeber, G R Matsueda, J F Aubert, et al.
American Journal of Hypertension
|
May 1, 1991
In vitro effects of DuP 753, a nonpeptide angiotensin II receptor antagonist, on human platelets and rat vascular smooth muscle cells
M Burnier, G Centeno, E Grouzmann, et al.
Page
of 46
Search research articles
Search
Showing results (291-300 of 458) with videos related to
Sort By:
Page
of 46
British Journal of Clinical Pharmacology
|
October 1, 1989
Atrial natriuretic peptide and urinary prostaglandins in man
D Benzoni, J Geoffroy, B Waeber, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1987
Acute antihypertensive effect of angiotensin converting enzyme inhibition and calcium entry blockade
H R Brunner, J Nussberger, J Bidiville, et al.
Life Sciences
|
December 7, 1987
Markedly reduced blood pressure responsiveness in endotoxemic rats; reversal by neuropeptide Y
D Evéquoz, B Waeber, R Corder, et al.
Clinical and Experimental Pharmacology & Physiology
|
February 1, 1994
Mechanisms of the pressor response to intravenous thyrotropin-releasing hormone in the rat
D Evequoz, M Burnier, M Niederberger, et al.
Kidney International. Supplement
|
June 1, 1996
Pharmacokinetic-pharmacodynamic relationships of three angiotensin II receptor antagonists in normal volunteers
M Burnier, T Buclin, J Biollaz, et al.
Journal of Cardiovascular Pharmacology
|
December 1, 1994
Neuropeptide Y infusion decreases plasma renin activity in postmyocardial infarction rats
R Zelis, J Nussberger, B Clemson, et al.
Experientia
|
October 15, 1994
Differential vascular effects of neuropeptide Y(NPY) selective receptor agonists
D Evéquoz, E Grouzmann, A G Beck-Sickinger, et al.
Schweizerische Medizinische Wochenschrift
|
December 31, 1983
[Treatment of hypertensive crisis with captopril]
J Biollaz, B Waeber, G A Turini, et al.
European Journal of Pharmacology
|
June 17, 1986
The hemodynamic response of conscious normotensive rats to atriopeptin III: Lack of a role of the parasympathetic nervous system
B Waeber, G R Matsueda, J F Aubert, et al.
American Journal of Hypertension
|
May 1, 1991
In vitro effects of DuP 753, a nonpeptide angiotensin II receptor antagonist, on human platelets and rat vascular smooth muscle cells
M Burnier, G Centeno, E Grouzmann, et al.
Page
of 46